Department of Military Affairs Tender by Indian Army (GEM/2025/B/6166862)

BETHANECHOL 25 MG TAB,INDOMETHACIN 25 MG CAP,HYDROCORTISONE 5 MG TAB,SEVELAMER 800 MG TAB,ALFUZOSIN

Goods
Qty:8.8L
EMD: ₹34,163
EST Bid: ₹41.2 Lakh
Department of Military Affairs Tender by Indian Army (GEM/2025/B/6166862)

Tender Timeline

Tender Issue
May 1, 2025 at 1:06 PM

Tender Title: ECHS BOQ01 2025

Reference Number: GEM/2025/B/6166862

The ECHS BOQ01 2025 tender is issued by the Department of Military Affairs, under the Ministry of Defence. This tender invites bids for the supply of various pharmaceutical products, including Bethanechol 25 mg Tablet, Indomethacin 25 mg Capsule, Hydrocortisone 5 mg Tablet, Sevelamer 800 mg Tablet, Alfuzosin, and Inj Trastuzumab Deruxtecan 100 mg.

Scope of Work and Objectives

The primary objective of this tender is to procure a total quantity of 879,693 units of specified medical products. This initiative aims to ensure that the healthcare needs of the armed forces are met with quality medicines in a timely manner. It is crucial that all suppliers adhere to the technical and quality specifications outlined in the tender documents.

Eligibility Criteria

To qualify for this tender, bidders must be registered entities with a valid license to operate in the pharmaceutical sector. Additionally, they must meet all regulatory compliance requirements and possess the necessary certifications to supply healthcare products.

Technical Requirements

Bidders are required to meet certain technical specifications outlined in the tender. This includes adhering to stringent quality standards relevant to pharmaceutical products, such as Good Manufacturing Practices (GMP) and other compliance requirements as mandated by health authorities.

Financial Requirements

Bidders must demonstrate financial stability, with evidence of sufficient working capital to undertake the procurement in question. This includes providing details concerning any Earnest Money Deposit (EMD) needed and outlining the payment terms acceptable by the issuing authority.

Document Submission Details

Interested parties must prepare and submit their documents electronically, adhering strictly to the formats specified in the tender documentation. All submissions should be complete and submitted before the specified deadline to be considered valid.

Special Provisions

This tender encourages bids from Micro, Small, and Medium Enterprises (MSEs), offering them advantages during the evaluation process. Furthermore, startups that are compliant with specific provisions will be given priority consideration as part of the government’s support for new ventures in the pharmaceutical sector.

Evaluation Process

Bids will be subjected to a comprehensive evaluation methodology, which will involve assessment against criteria such as pricing, adherence to specifications, and previous performance records. The price evaluation will consider various components, and the final decision will rest on the overall value for money.

Delivery Locations

Suppliers should be prepared to deliver the products to specified military healthcare facilities across the designated regions as detailed in the tender documents.

Contact Information

For further inquiries regarding this tender, bidders are encouraged to refer to the official channels provided in the tender documentation.

In summary, the ECHS BOQ01 2025 tender represents a significant procurement opportunity in the healthcare domain, aimed at fostering quality healthcare services for armed forces personnel.

Tender BOQ Items

61 Items
1.

BETHANECHOL 25 MG TAB

Qty:27300
Unit:no
30
2.

INDOMETHACIN 25 MG CAP

Qty:3000
Unit:no
30
3.

HYDROCORTISONE 5 MG TAB

Qty:600
Unit:no
30
4.

SEVELAMER 800 MG TAB

Qty:3360
Unit:no
30
5.

ALFUZOSIN 10 MG TAB

Qty:12120
Unit:no
30
6.

BRIVARACETAM 50MG TAB

Qty:6000
Unit:no
30
7.

DONEPEZIL 5 MG TAB

Qty:15000
Unit:no
30
8.

CILNIDIPINE 10 MG TAB

Qty:96300
Unit:no
30
9.

ETHAMBUTOL 200 MG TAB

Qty:1800
Unit:no
30
10.

DAPAGLIFOZIN 5MG TAB

Qty:4800
Unit:no
30
11.

THYROXINE 75 MCG TAB

Qty:32400
Unit:no
30
12.

THIAMINE 100MG TAB

Qty:3600
Unit:no
30
13.

LEVOSULPIRIDE 25MG TAB

Qty:14580
Unit:no
30
14.

BICALUTAMIDE 50MG TAB

Qty:9780
Unit:no
30
15.

HYDROXYPROGESTERONE 500 MG

Qty:600
Unit:no
30
16.

MESALAMINE SUPPOSITORY

Qty:360
Unit:no
30
17.

ACOTIAMIDE 100MG TAB

Qty:1200
Unit:no
30
18.

CILOSTAZOL 100 MG TAB

Qty:4200
Unit:no
30
19.

ACENOCOUMAROL 2 MG TAB

Qty:13320
Unit:no
30
20.

DILTIAZEM 90MG SR TAB

Qty:13800
Unit:no
30
21.

MEGESTROL ACETATE 160 MG TAB

Qty:3180
Unit:no
30
22.

MOXONIDINE 0.2MG TAB

Qty:9360
Unit:no
30
23.

NITROGLYCERIN 2.6MG TAB

Qty:30000
Unit:no
30
24.

ETIZOLAM 0.5MG TAB

Qty:10800
Unit:no
30
25.

SALICYLIC ACID Plus COAL TAR OINT

Qty:600
Unit:no
30
26.

CLOZAPINE 25 MG TAB

Qty:2400
Unit:no
30
27.

METRONIDAZOLE 30GM OINT

Qty:360
Unit:no
30
28.

SILVER SULFADIAZINE 1 percent OINT 500 GMS JAR

Qty:54
Unit:no
30
29.

DICYCLOMINE 10MG plus MEFENAMIC ACID 250MG TAB

Qty:16920
Unit:no
30
30.

TADALAFIL 10MG TAB

Qty:2400
Unit:no
30
31.

POVIDONE IODINE 200 MG PESSARY

Qty:60
Unit:no
30
32.

CARBIMAZOLE 5MG TAB

Qty:19920
Unit:no
30
33.

DORZOLAMIDE 2 percent W per V plus TIMOLOL 0point 5 percent W per V Eye Drop

Qty:876
Unit:no
30
34.

SYP SALBUTAMOL 100ML

Qty:1332
Unit:no
30
35.

LULICONAZOLE CREAM

Qty:2082
Unit:no
30
36.

LEVOSALBUTAMOL 50MCG plus BECLOMETASONE 50MCG INHALER

Qty:1038
Unit:no
30
37.

HEPARIN 15G or 20G OINT

Qty:192
Unit:no
30
38.

CILNIDIPINE 5 MG TAB

Qty:18000
Unit:no
30
39.

TAMSULOSIN 0.4 MG TAB

Qty:137400
Unit:no
30
40.

LEFLUNOMIDE 10 MG TAB

Qty:5400
Unit:no
30
41.

ATORVASTATIN 40MG TAB

Qty:10800
Unit:no
30
42.

ACENOCOUMAROL 1 MG TAB

Qty:14580
Unit:no
30
43.

BISOPROLOL 5MG TAB

Qty:27900
Unit:no
30
44.

DULOXETINE 20MG CAP

Qty:24960
Unit:no
30
45.

TORSEMIDE 10MG TAB

Qty:39480
Unit:no
30
46.

FORMOTEROL 6MCG plus BUDESONIDE 200MCG RC

Qty:18720
Unit:no
30
47.

RECOMBINANT HUMAN ERYTHROPOIETIN ALFA 20000IU INJ

Qty:180
Unit:no
30
48.

INJ METHYLCOBALAMIN 1000MCG plus VITAMIN B6 PYRIDOXINE 100MG plusNICOTINAMID

INJ METHYLCOBALAMIN 1000MCG plus VITAMIN B6 PYRIDOXINE 100MG plusNICOTINAMIDE

Qty:3420
Unit:no
30
49.

FENOFIBRATE 160MG TAB

Qty:15900
Unit:no
30
50.

MOXONIDINE 0 point 3MG TAB

MOXONIDINE 0 .3MG TAB

Qty:7200
Unit:no
30
51.

OXCARBAZEPINE 150 MG TAB

Qty:21600
Unit:no
30
52.

PRAMIPEXOLE 0 point 25MG TAB

Qty:1800
Unit:no
30
53.

SERTRALINE 50 MG TAB

Qty:26760
Unit:no
30
54.

TIOTROPIUM BROMIDE 9 MCG 120 METERED DOSES per UNIT INHALE

TIOTROPIUM BROMIDE 9 MCG, 120 METERED DOSES/UNIT, INHALE

Qty:390
Unit:no
30
55.

TOPIRAMATE 50MG TAB

Qty:5160
Unit:no
30
56.

TAMSULIN 0 point 4 MG plus DUTASTERIDE 5 MG TAB TAB

Qty:58080
Unit:no
30
57.

LATANOPROST 0 point 005 percent W per V EYE DROPS

Qty:966
Unit:no
30
58.

TRIMETAZIDINE MR 35 MG TAB

Qty:19800
Unit:no
30
59.

CLONAZEPAM 0 point 5MG TAB

CLONAZEPAM 0.5MG TAB

Qty:54600
Unit:no
30
60.

CHOLINE SALICYLATE 8.7 percent plus LIDOCAINE 2 plus

Qty:894
Unit:no
30
61.

Inj Trastuzumab Deruxtecan 100 mg

Qty:9
Unit:no
30

General Information

Item Category
BETHANECHOL 25 MG TAB , INDOMETHACIN 25 MG CAP , HYDROCORTISONE 5 MG TAB , SEVELAMER 800 MG TAB , ALFUZOSIN 10 MG TAB , BRIVARACETAM 50MG TAB , DONEPEZIL 5 MG TAB , CILNIDIPINE 10 MG TAB , ETHAMBUTOL 200 MG TAB , DAPAGLIFOZIN 5MG TAB , THYROXINE 75 MCG TAB , THIAMINE 100MG TAB , LEVOSULPIRIDE 25MG TAB , BICALUTAMIDE 50MG TAB , HYDROXYPROGESTERONE 500 MG , MESALAMINE SUPPOSITORY , ACOTIAMIDE 100MG TAB , CILOSTAZOL 100 MG TAB , ACENOCOUMAROL 2 MG TAB , DILTIAZEM 90MG SR TAB , MEGESTROL ACETATE 160 MG TAB , MOXONIDINE 0.2MG TAB , NITROGLYCERIN 2.6MG TAB , ETIZOLAM 0.5MG TAB , SALICYLIC ACID Plus COAL TAR OINT , CLOZAPINE 25 MG TAB , METRONIDAZOLE 30GM OINT , SILVER SULFADIAZINE 1 percent OINT 500 GMS JAR , DICYCLOMINE 10MG plus MEFENAMIC ACID 250MG TAB , TADALAFIL 10MG TAB , POVIDONE IODINE 200 MG PESSARY , CARBIMAZOLE 5MG TAB , DORZOLAMIDE 2 percent W per V plus TIMOLOL 0point 5 percent W per V Eye Drop , SYP SALBUTAMOL 100ML , LULICONAZOLE CREAM , LEVOSALBUTAMOL 50MCG plus BECLOMETASONE 50MCG INHALER , HEPARIN 15G or 20G OINT , CILNIDIPINE 5 MG TAB , TAMSULOSIN 0.4 MG TAB , LEFLUNOMIDE 10 MG TAB , ATORVASTATIN 40MG TAB , ACENOCOUMAROL 1 MG TAB , BISOPROLOL 5MG TAB , DULOXETINE 20MG CAP , TORSEMIDE 10MG TAB , FORMOTEROL 6MCG plus BUDESONIDE 200MCG RC , RECOMBINANT HUMAN ERYTHROPOIETIN ALFA 20000IU INJ , INJ METHYLCOBALAMIN 1000MCG plus VITAMIN B6 PYRIDOXINE 100MG plusNICOTINAMID , FENOFIBRATE 160MG TAB , MOXONIDINE 0 point 3MG TAB , OXCARBAZEPINE 150 MG TAB , PRAMIPEXOLE 0 point 25MG TAB , SERTRALINE 50 MG TAB , TIOTROPIUM BROMIDE 9 MCG 120 METERED DOSES per UNIT INHALE , TOPIRAMATE 50MG TAB , TAMSULIN 0 point 4 MG plus DUTASTERIDE 5 MG TAB TAB , LATANOPROST 0 point 005 percent W per V EYE DROPS , TRIMETAZIDINE MR 35 MG TAB , CLONAZEPAM 0 point 5MG TAB , CHOLINE SALICYLATE 8.7 percent plus LIDOCAINE 2 plus , Inj Trastuzumab Deruxtecan 100 mg
Ministry Name
Organisation Name

Financial Information

Estimated Bid Value
₹41,21,761.20
EMD Amount
₹34,163.00
Bid Offer Validity
180 (Days)
Arbitration Clause
No
Mediation Clause
No

Evaluation and Technical Information

Evaluation Method
Item wise evaluation/
RA Qualification Rule
H1-Highest Priced Bid Elimination
Inspection Required
Yes
Technical Clarifications Time
2 Days

Tender Documents

5 Documents
GeM-Bidding-7769341.pdfMain Document
BOQ DocumentBOQ BOQ
BOQ DocumentBOQ BOQ
Buyer uploaded ATC documentATC ATC
GEM General Terms and Conditions DocumentGEM_GENERAL_TERMS_AND_CONDITIONS

Documents Required from Seller

  • Bidder Turnover
  • Certificate (Requested in ATC)
  • OEM Authorization Certificate
  • OEM Annual Turnover
  • Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
  • the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Similar Tenders

View All

Frequently Asked Questions

The eligibility requirements include being a registered entity in the pharmaceutical sector, possessing necessary licenses and certifications, and adhering to all relevant regulatory compliance standards. Suppliers must also demonstrate financial stability through adequate capital to undertake the contract.

Bidders must provide all relevant certificates that validate their capability to supply pharmaceuticals. Key certifications include Good Manufacturing Practice (GMP), FDA approval if applicable, and any other certifications pertinent to the quality and safety of the products being supplied.

The registration process involves submitting required documents electronically as outlined in the tender documentation. Participants must ensure compliance with specified formats and criteria, submitting their applications ahead of the deadline to avoid disqualification.

The accepted document formats include PDF, Word, and Excel files, among others as prescribed in the tender documentation. It is vital for bidders to adhere strictly to the specified formats to ensure their submissions are accepted.

The performance security requirements typically involve a financial guarantee presented by the winning bidder to ensure compliance with the contract terms. This may include a bank guarantee or a deposit equivalent to a percentage of the contract value, ensuring that total performance meets the standards outlined in the tender.

Probable Bidders

Companies likely to bid

Get Tender Alerts

Get notifications for similar tenders